Related Experiment Videos

[Clinico-pathological evaluation of patients with homozygous familial hypercholesterolemia]

F P D'Armiento1, F Di Gregorio, C Napoli

  • 1Istituto di Anatomia patologica, II Facoltà di Medicina e Chirurgia, Università, Napoli.

Insights

Homozygous Familial Hypercholesterolemia (FHO) patients exhibit severe cardiovascular disease and anatomic abnormalities due to high LDL-cholesterol. Lipid peroxidation, indicated by malondialdehyde levels, is also present in these patients.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Familial Hypercholesterolemia (FHO) is a severe autosomal genetic disorder.
  • It results from mutations in the LDL receptor gene, leading to high plasma LDL-cholesterol and B-Apolipoprotein.
  • This causes significant anatomic and pathological abnormalities.

Purpose of the Study:

  • To investigate the clinical and pathological findings in patients with Homozygous Familial Hypercholesterolemia (FHO).
  • To assess lipid peroxidation markers in FHO patients.

Main Methods:

  • Study included 8 patients diagnosed with FHO.
  • Clinical data on anatomic/pathologic abnormalities were collected.
  • Malondialdehyde (MDA) levels were measured in plasma and atherosclerotic plaques from one autoptic case.

Main Results:

  • Patients presented with severe cardiovascular disease and cutaneous xanthomatosis.
  • Elevated LDL-cholesterol and B-Apolipoprotein levels were confirmed.
  • Malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were measured.

Conclusions:

  • Homozygous Familial Hypercholesterolemia (FHO) leads to severe health complications.
  • Lipid peroxidation may play a role in the pathophysiology of FHO.
  • Early diagnosis and management are crucial for FHO patients.

Related Concept Videos